Warm Autoimmune Hemolytic Anemia (WAIHA) Market

The total prevalent population of Warm Autoimmune Hemolytic Anemia in 7MM was 82,045 in 2017. Among the seven major markets it is observed that the females are more affected with WAIHA as compared to males.

In 2017 the market size of Warm Autoimmune Hemolytic Anemia (WAIHA) in 7MM was USD 368 million, which is expected to increase during the forecast period (2017-2030).

Some of the key players involved in developing therapies for WAIHA include Rigel Pharmaceuticals, Apellis Pharmaceuticals, Momenta Pharmaceuticals, Immunovant, Alexion Pharmaceuticals, Sanofi and many others.

For more details on Warm Autoimmune Hemolytic Anemia (WAIHA) market includes: https://www.delveinsight.com/report-store/warm-autoimmune-hemolytic-anemia-waiha-market